RxDoctor Payments Data

Joshua Fosnot, MD

Plastic and Reconstructive Surgery · Philadelphia, PANPI 1306990114

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by RTI Surgical, Inc at 50.3% of the total. 2025 is the largest year on record at $7,492, more than ten times the $96 reported in 2019.

$12,100in general payments, 2019–2025

Across 41 payments — averaging $295.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • RTI Surgical, Inc$6K
  • Davol Inc.$3K
  • Integra Lifesciences Corporation$2K
  • Mentor Worldwide LLC$324
  • TELA Bio, Inc.$188
  • AbbVie$170
  • plus $323 from 6 others

What the payments were for

  • Consulting fees$4,55038%
  • Speaking & faculty fees$5,80048%
  • Food & beverage$1,75014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,100 in reported general payments places this provider in the 85th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$87,983
Medicare patients
83
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →